FREND COVID19 Ag

FREND COVID19 Ag


Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
South Korea
Payment Terms
Negotiable
Production method
Negotiable
Shipping / Lead Time
Negotiable / Negotiable
Keyword
ag, antigen, covid, covid-19
Category
Medical Devices
tK Meet
tK Meet

Apply a video call to the Supplier

SEND TO SUPPLIER INQUIRY

NanoEnTek Inc.

Country / Year Established
South Korea South Korea / 2000
Business type
Manufacturer
Verified Certificate

16

TRADE TOWER

DUNS

Product name FREND COVID19 Ag Certification -
Category Medical Devices Ingredients -
Keyword ag , antigen , covid , covid-19 Unit Size -
Brand name - Unit Weigh -
origin South Korea Stock -
Supply type - HS code -

Product Information

The FREND™ COVID-19 Ag is a fluorescence immunoassay (FIA) for use with the FREND™ System. It is designed for the qualitative detection of the nucleocapsid protein of SARS-CoV-2 directly from nasopharyngeal swab specimens directly from individuals suspected with COVID-19 by their healthcare provider. 

 

 

FREND COVID-19 Ag is

- A fluorescence immunoassay (FIA) for use with the FREND System.

- Designed for the qualitative detection of the nucleocapsid protein of SARS-CoV-2 directly from nasopharyngeal swab specimen.

- Demonstrates reliable and objective results in just 3 minutes with one drop or 35 uL of sample.

- Cartridge designed for insertion into FREND system.

 

KEY FEATURES & BENEFITS
- 3 minutes  |  Fast result

- 2 steps  |  Easy to use

- 94.12% & 100%  |  Positive & Negative Percent Agreement

- Microfluidic Qualitative Immunoassay

- LIS connectivity (data management)

 

FREND COVID-19 Ag is a single use fluorescence immunoassay (FIA) kit that can detect the presence of the nucleocapsid protein of SARS-CoV-2 in nasopharyngeal swab specimen via sandwich immunoassay. The lysis buffer extracts virus from the swab specimen and releases viral proteins.

Within FREND COVID-19 Ag cartridge, the released nucleocapsid proteins are captured by antibody specific to the nucleocapsid protein from SARS-CoV-2 and detected by antibody conjugated to fluorescent micro-particles. The FREND System analyzes fluorescence intensity of control zone for validity of the test and the test zone for the presence of the nucleocapsid protein and displays the result on the screen.

 

Clinical Performance Evaluation


A total of 109 clinical samples (34 positive and 75 negative) confirmed with RT-PCR were tested with the FREND™ COVID-19 Ag. It shows 94.12% PPA (Positive Percent Agreement) and 100% NPA (Negative Percent Agreement) as shown below.

 

Effective Data Management

Laboratory Information System Connectivity

In the event of a pandemic, the management of a vast amount of clinical result is important. However, many laboratories face the challenge in arranging the essential information effectively(1).

The FREND™ System which is LIS compatible provide following features:

 

 

Specification

 

ItemSpecification
Assay methodFluorescence immunoassay
Sample typeNasopharyngeal swab
Sample volume35 uL
Time to result< 3 min
Quantity20 tests/kit
Storage condition2 ~ 30 °C (35 ~ 86 °F)

 

For more information, please visit www.nanoentek.com

 

 

B2B Trade

Price (FOB) Negotiable transportation -
MOQ Negotiable Leadtime Negotiable
Payment Options Negotiable Shipping time Negotiable

NanoEnTek Inc.

Country / Year Established
South Korea South Korea / 2000
Business type
Manufacturer

16

TRADE TOWER

DUNS

President
Chanil Chung
Address
Guro-gu, Guro-dong,235-2, Guro-gu, Seoul, Korea
Product Category
Medical Devices
Year Established
2000
No. of Total Employees
101-500
Company introduction

 

Main Markets

Germany Germany

Italy Italy

Japan Japan

Taiwan Taiwan

U. Kingdom U. Kingdom

Main Product

Related Products

Other buyers also search

Membership Grade

BUYER

Biz Pro VIP

SELLER

Biz Pro VIP
팝업닫기
Live Chat A new message arrives
from a business partner.

No Data

  • There is no data to load
  • Check out the My tK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more